| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| R846434 | 101328-85-2 | (R)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮, 95% (R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one, 95% |
C11H13N3O | |
| R995857 | 1630760-60-9 | (R)-DNMDP, ≥99% (R)-DNMDP, ≥99% |
C15H20N4O3 | |
| D851662 | 149524-64-1 | (R)-N-Boc-2-氨基环己酮, ≥95% (R)-N-Boc-2-aminocyclohexanone, ≥95% |
C11H19NO3 | |
| S836456 | 33878-99-8 | (S)-(+)-3,4,8,8a-四氢-8a-甲基-1,6-(2H,7H)-萘二酮, 99% (S)-(+)-3,4,8,8a-Tetrahydro-8a-methyl-1,6(2H,7H)-naphthalenedione, 99% |
C11H14O2 | |
| S833593 | 101711-78-8 | (S)-(+)-4-苄基-3-丙酰-2-恶唑 N-酮, 98% (S)-(+)-4-BENZYL-3-PROPIONYL-2-OXAZOLIDI N-ONE, 98% |
C13H15NO3 | |
| S921769 | 58879-34-8 | (S)-(+)-二氢-5-(对甲苯基磺酰氧基甲基)-2(3H)-呋喃酮, 98% (S)-(+)-Dihydro-5-(p tolylsulfonyloxymethyl)-2(3H)-fu ranone, 98% |
C12H14O5S | |
| S673541 | 1517965-94-4 | (S)-(2-((3-(5-Fluoropyridin-2-yl)-1H-pyrazol-1-yl)methyl)-1,3-oxazinan-3-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone, ≥99% (S)-(2-((3-(5-Fluoropyridin-2-yl)-1H-pyrazol-1-yl)methyl)-1,3-oxazinan-3-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone, ≥99% |
C23H22FN7O2 | |
| S784426 | 865430-51-9 | (S)-1,5,10,11a-四氢-3H-苯并[e]吡咯并[1,2-a][1,4]二氮杂卓-3,11(2H)-二酮, 98% (S)-1,5,10,11a-Tetrahydro-3H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-3,11(2H)-dione, 98% |
C12H12N2O2 | |
| S995031 | 936563-97-2 | (S)-1-(3-(4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基)哌啶-1-基)丙-2-烯 -1-酮(伊布替尼/依鲁替尼杂质), 97% (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (Ibrutinib Impurity), 97% |
C25H24N6O2 | |
| S649223 | 1228632-60-7 | (S)-1-(4-benzylpiperazin-1-yl)-2-hydroxypropan-1-one, 95% (S)-1-(4-benzylpiperazin-1-yl)-2-hydroxypropan-1-one, 95% |
C14H20N2O2 | |
| S679889 | 1265900-08-0 | (S)-1-Boc-4-羟基哌啶-2-酮, 97% (S)-1-Boc-4-hydroxypiperidin-2-one, 97% |
C10H17NO4 | |
| D851651 | 93371-30-3 | (S)-1-氯-3-(Boc-氨基)-2-丁酮, ≥97% (S)-3-(Boc-amino)-1-chloro-2-butanone, ≥97% |
C9H16ClNO3 | |
| S762724 | 1369969-44-7 | (S)-2-(2-羟基-3-((4-(3-氧代吗啉)苯基)氨基)丙基)异吲哚啉-1,3-二酮, 94% 2-[(2S)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione, 94% |
C21H21N3O5 | |
| S840081 | 99208-71-6 | (S)-3,3-二甲基四氢吡咯并[1,2-c]噁唑-5-(3H)-酮, 95% (S)-3,3-Dimethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one, 95% |
C8H13NO2 | |
| S855374 | 1369530-77-7 | (S)-3-(4-溴-3-氟苯基)-5-羟甲基恶唑烷-2-酮, 97% (S)-3-(4-bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one , 97% |
C10H9BrFNO3 | |
| S645690 | 16750-82-6 | (S)-3-Methyl-6β-isopropenyl-2-cyclohexene-1-one, 95% (S)-3-Methyl-6β-isopropenyl-2-cyclohexene-1-one, 95% |
C10H14O | |
| S919575 | 78551-38-9 | (S)-3-甲基哌嗪-2-酮, 95% (S)-3-Methylpiperazin-2-one, 95% |
C5H10N2O | |
| S831229 | 34368-52-0 | (S)-3-羟基-2-吡咯烷酮, 97% (S)-3-Hydroxy-2-pyrrolidone, 97% |
C4H7NO2 | |
| D650889 | 142937-55-1 | (S)-4,5-Dihydroxy-2,3-pentandione, 98%(¹H NMR), 1mg/mL in H2O (S)-4,5-Dihydroxy-2,3-pentandione, 98%(¹H NMR), 1mg/mL in H2O |
C5H8O4 | |
| S764251 | 612492-55-4 | (S)-4-((叔丁基二甲基硅烷基)氧基)-5,5-二甲基己-2-酮, 97% (S)-4-((tert-Butyldimethylsilyl)oxy)-5,5-dimethylhexan-2-one, 97% |
C14H30O2Si |